X

Geisinger Medical Center Selects CDEX Inc.’s (CEXI.OB) ValiMedTM Medication Safety System

Worldwide studies have proven that high-risk medication compounding errors in pharmacies continue to cause significant harm to patients and monetary loss to hospitals. Today, CDEX, Inc. announced that Geisinger Medical Center has joined a growing list of world-class hospitals that are proactively addressing this issue by selecting the ValiMed™ Medication Safety System to assure the “Right Drug at the Right Dose” every time.

“After reading the University of Michigan Health System study that documented ValiMed’s identification of five major medical mistakes over an 18 month period at one hospital, I knew that we needed to bring that technology in-house,” stated John Jones, Geisinger Vice President, System Therapeutics. “We purchased two ValiMed units to provide additional assurance of accuracy of our compounding practices.”

“We are honored that Geisinger Medical Center selected ValiMed as part of its Medication Safety Program and look forward to working with John and his staff in integrating ValiMed into their daily practices,” commented Greg Firmbach, Senior Vice President of CDEX.

Let us hear your thoughts below:

Related Post